Table 2 Safety of convalescent plasma in the per-protocol analysis

Overall

14 (31.1%)

13 (28.3%)

0.87 (0.32 to 2.36)

Serious

13 (28.9%)

11 (23.9%)

0.78 (0.27 to 2.18)

MV

10 (22.2%)

7 (15.2%)

–

ICU admission

0 (0.0%)

2 (4.4%)

–

Pulmonary embolism

1 (2.2%)

1 (2.2%)

–

DVT

0 (0.0%)

1 (2.2%)

–

Pneumatocele

1 (2.2%)

0 (0.0%)

–

Readmission

1 (2.2%)

0 (0.0%)

–

Non-serious^a

1 (2.2%)

2 (4.4%)

2.0 (0.10 to 120.54)

Rash with pruritus

1 (2.2%)

1 (2.2%)

–

Palpebral edema

0 (0.0%)

1 (2.2%)

–